Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Colorado Gynecologic Oncology Group
Aurora, Colorado, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- University of Massachusetts Medical School
Worcester, Massachusetts, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- North Shore University Hospital
Manhasset, New York, United States
- North Shore-Lij Health System Ccop
Manhasset, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Mount Carmel Health Center West
Columbus, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Cancer Care Associates-Midtown
Tulsa, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Lehigh Valley Hospital
Allentown, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- University of Texas Medical Branch at Galveston
Galveston, Texas, United States
- Carilion Clinic Gynecological Oncology
Roanoke, Virginia, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2007
- Primary completion
- 31 Jul 2011
- Completion
- —
- Last update posted
- 11 Jan 2018
- Registered enrollment
- 51
- Registry id
- NCT00499252
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.